For the future, it would be interesting to perform an fMRI study in which the relationship between hyperphagia, GLP-1, and neural regions involved in hunger and satiety are assessed in PWS patients, since GLP-1 agonists are known to lower feelings of hunger and increase feelings of fullness, and are therefore currently used in the treatment of obesity [62]. The gene discussed is GCG; the disease is obesity disorder.